arrow
K

Kwok-Leung Cheung

University of Nottingham
H指数:50
被引数:8,444

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The ESMO/SIOG Cancer in the Elderly Working Group pragmatic strategies for clinical trial designs and endpoints in older adults with cancer

ESMO/SIOG老年肿瘤工作组关于老年癌症患者临床试验设计与终点的实用策略

2026-02-230
OAAI
Impact of whole breast irradiation, endocrine therapy or their combination on outcomes of early-stage, luminal A-like, low-risk, breast cancer patients aged 65 years or over: insights from the EUSOMA database
2026-01-300
PRE
Survival and Extent of Breast Surgery in Patients with Complete Response After Neoadjuvant Therapy: A Retrospective Analysis from the EUSOMA Database

新辅助治疗后完全缓解患者的乳腺癌手术生存率及手术范围:EUSOMA数据库的回顾性分析

Cancers
IF4.4
2026-01-010
OA
Clinico-pathological features predicting indication to mastectomy in breast cancer patients achieving complete response after neoadjuvant therapy: A retrospective analysis of the EUSOMA database

临床病理特征预测乳腺癌患者在新辅助治疗后获得完全缓解的乳房切除术指征: 对EUSOMA数据库的回顾性分析

EJSO
IF2.9
2025-06-011
PRE
Preferences for quality of life versus length of life in older women deciding about treatment for early breast cancer: A cross-sectional sub-analysis of the Bridging the Age Gap study
2025-05-010
PRE
The care of older patients with cancer across the United Kingdom in 2024: A narrative review by the International Society of Geriatric Oncology UK Country Group
2025-01-010
PRE
A multiomic approach for camizestrant-induced estrogen receptor (ER) degradation, antagonism and anti-proliferation: Exploratory analysis from SERENA-3

一种针对卡米泽米特诱导的雌激素受体(ER)降解、拮抗和抗增殖的多组学方法:SERENA-3研究的探索性分析

2024-09-010
PRE
SERENA-3: A randomized pre-surgical window of opportunity study assessing dose and duration of camizestrant treatment in post-menopausal women with ER-positive, HER2-negative primary breast cancer
2024-05-022
PRE